{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:25:15Z","timestamp":1793499915481,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.amjcard.2023.06.047","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T23:10:38Z","timestamp":1704496238000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Risk of Appropriate Implantable Cardioverter-Defibrillator Therapies and Sudden Cardiac Death in Patients With Heart Failure With Improved Left Ventricular Ejection Fraction"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3064-7887","authenticated-orcid":false,"given":"Mohammed","family":"Al-Sadawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Gier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Almasry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-7006","authenticated-orcid":false,"given":"Eric","family":"Rashba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.06.047_bib0001","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0003","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.119.043012","article-title":"Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score-matched analysis from the Swedish heart failure registry","volume":"140","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0004","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.2014.5310","article-title":"Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%","volume":"311","author":"Al-Khatib","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0006","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ehjci\/jeab226","article-title":"Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy","volume":"23","author":"Rettl","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0007","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0008","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/europace\/euaa414","article-title":"Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis","volume":"23","author":"Yuyun","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0009","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.19102\/icrm.2022.13121","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapies after generator replacement-a pooled analysis of 31,640 patients\u2019 data","volume":"13","author":"Khanra","year":"2022","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/pace.12850","article-title":"Estimating the risks and benefits of implantable cardioverter defibrillator generator replacement: a systematic review","volume":"39","author":"Lewis","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0011","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.hrthm.2020.01.005","article-title":"Outcomes following implantable cardioverter-defibrillator generator replacement in adults: a systematic review","volume":"17","author":"McCarthy","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0012","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2018.12.068","article-title":"Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: results of a meta-analysis","volume":"283","author":"Rordorf","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0013","first-page":"e210","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0014","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0015","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0016","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0017","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2017.1413","article-title":"Association of implantable cardioverter defibrillators with survival in patients with and without improved ejection fraction: secondary analysis of the sudden cardiac death in heart failure trial","volume":"2","author":"Adabag","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0018","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/jce.13037","article-title":"Impact of improved left ventricular systolic function on the recurrence of ventricular arrhythmia in heart failure patients with an implantable cardioverter-defibrillator","volume":"27","author":"Kim","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0019","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0735-1097(01)01404-8","article-title":"Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy","volume":"38","author":"Wittstein","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0735-1097(97)00248-9","article-title":"Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure","volume":"30","author":"B\u00f6hm","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0021","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000068316.53218.49","article-title":"Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure","volume":"107","author":"Reiken","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0022","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardfail.2007.01.005","article-title":"Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy","volume":"13","author":"Iyengar","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacc.2007.07.087","article-title":"Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders","volume":"51","author":"Vanderheyden","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0024","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.114.009081","article-title":"Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National cardiovascular Data Registry","volume":"130","author":"Prutkin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0025","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.hrthm.2014.06.018","article-title":"Generator replacement is associated with an increased rate of ICD lead alerts","volume":"11","author":"Lovelock","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2023.06.047_bib0026","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","article-title":"Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry","volume":"122","author":"Poole","year":"2010","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923004435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923004435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:02:59Z","timestamp":1792166579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923004435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":26,"alternative-id":["S0002914923004435"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.047","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.167821396.66197879\/v1","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Appropriate Implantable Cardioverter-Defibrillator Therapies and Sudden Cardiac Death in Patients With Heart Failure With Improved Left Ventricular Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}